Financials data is unavailable for this security.
View more
Year on year Guardant Health Inc grew revenues 25.45% from 449.54m to 563.95m while net income improved from a loss of 654.59m to a smaller loss of 479.45m.
Gross margin | 60.31% |
---|---|
Net profit margin | -74.02% |
Operating margin | -75.43% |
Return on assets | -30.72% |
---|---|
Return on equity | -609.28% |
Return on investment | -35.19% |
More ▼
Cash flow in USDView more
In 2023, Guardant Health Inc increased its cash reserves by 698.66%, or 991.74m. Cash Flow from Investing totalled 840.25m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 324.98m for operations while cash generated from financing totalled 477.38m.
Cash flow per share | -3.87 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.488 |
---|---|
Tangible book value per share | -0.5736 |
More ▼
Balance sheet in USDView more
Current ratio | 6.22 |
---|---|
Quick ratio | 5.85 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.06 |
More ▼